当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 利润表

戴维医疗

(300314)

  

流通市值:21.04亿  总市值:42.16亿
流通股本:1.44亿   总股本:2.88亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入251,256,793.39121,163,868.56527,026,028.11402,925,721.56
  营业收入251,256,793.39121,163,868.56527,026,028.11402,925,721.56
二、营业总成本206,184,417.31100,821,497453,517,695.61335,740,052.47
  营业成本104,529,425.8851,945,737.99229,413,073.35174,144,094.74
  税金及附加2,972,492.27858,533.26,886,454.853,844,503.01
  销售费用45,224,299.7620,993,021.4107,551,186.7878,471,072.93
  管理费用32,803,000.8614,751,351.1764,892,027.2645,909,038.37
  研发费用25,524,506.5813,897,552.955,459,129.0138,881,143.78
  财务费用-4,869,308.04-1,624,699.66-10,684,175.64-5,509,800.36
  其中:利息费用226,363.22440,230.27472,108.92365,287.52
  其中:利息收入4,856,215.641,908,155.2210,713,701.667,504,563.44
三、其他经营收益
  加:公允价值变动收益--435,315.07-
  加:投资收益7,928,854.872,910,678.58-10,073,085.92-873,836.79
  资产处置收益-104,015.1-35,029.41-7,567.964,578.89
  资产减值损失(新)---5,006,911.77-
  信用减值损失(新)-867,144.55-849,851.23-298,130.3-1,917,759.3
  其他收益6,457,659.713,472,227.9310,236,111.167,517,469.38
四、营业利润58,487,731.0125,840,397.4368,794,062.7871,916,121.27
  加:营业外收入48,687.0225,710.37817,090.27196,909.73
  减:营业外支出506,782.44370.086,228,998.62226,921.15
五、利润总额58,029,635.5925,865,737.7263,382,154.4371,886,109.85
  减:所得税费用7,052,941.33,298,068.686,118,840.38,578,237.79
六、净利润50,976,694.2922,567,669.0457,263,314.1363,307,872.06
(一)按经营持续性分类
  持续经营净利润50,976,694.2922,567,669.0457,263,314.1363,307,872.06
(二)按所有权归属分类
  归属于母公司股东的净利润50,976,694.2922,567,669.0457,263,314.1363,307,872.06
  扣除非经常损益后的净利润40,710,888.2317,426,403.7152,197,201.3558,691,874.51
七、每股收益
  (一)基本每股收益0.180.080.20.22
  (二)稀释每股收益0.180.080.20.22
八、其他综合收益3,245,598.9416,486.79-578,357.06306,790.36
  归属于母公司股东的其他综合收益3,245,598.9416,486.79-578,357.06306,790.36
九、综合收益总额54,222,293.1922,984,155.8356,684,957.0763,614,662.42
  归属于母公司股东的综合收益总额54,222,293.1922,984,155.8356,684,957.0763,614,662.42
公告日期2025-08-222025-04-282025-04-092024-10-23
审计意见(境内)标准无保留意见
TOP↑